Omay, Dallas T.
HRN: 22-76-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2023
CEFUROXIME 750MG (VIAL)
12/16/2023
12/22/2023
IV
250mg
Q8
AGE;URTI
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes